Seminars

Main Content

2022 Seminars

Date
Speaker
Department
Title
2/2/22Dr. Thomas SchererMedical University of Vienna, AustriaLeptin-A regulator of hepatic lipid mechanism
3/2/22Dr. Jennifer StancillMedical College of WisconsinProtective Mechanisms Pancreatic β-cells: From Antioxidants to Antivirals
3/9/22Dr. Kathleen CoreyHarvard Medical SchoolNon-Alcoholic Fatty Liver Disease as a Risk Factor for Cardiovascular Disease
3/16/22Dr. Lisandra de Castro BrasEast Carolina University Using Natural Peptides To Prevent  Long-term Adverse Cardiac Remodeling
4/27/22Dr. Renata PereriaUniversity of IowaATF4 Integrates Mitochondrial Stress in Brown Adipose Tissue with Improved Metabolic Fitness
5/4/22Dr. Sonia NajjarOhio UniversityIs Non-alcoholic Steatohepatitis an Insulin Resistance Disease?
5/11/22Dr. Marat FudimDuke UniversityNAFLD and Heart Failure
5/25/22Dr. Harini SampathRutgers UniversityRegulation of Metabolic Health by Intestinal Delta-9 Desaturases
6/22/22Dr. Robert RaffaiUniversity of California-San Francisco ParnassusMacrophage Exosomes as mediators and therapeutics for cardiometabolic inflammation
7/20/22Dr. Keisa MathisUniversity of North Texas Health Science CenterUnderstanding the pathogenesis of lupus hypertension and renal injury
8/10/22Dr. Pooja ShuklaUniversity of MissouriA simple, non-invasive model to characterize pulmonary oxygen transport
9/14/22Dr. Bryan BeckerUniversity of Alabama, BirminghamAn update on renal nerves, salt and blood pressure control 
10/5/22Dr. Osvaldo Rivera-GonzalezNational Institutes of Diabetes and Digestive and Kidney DiseasesInvestigating GI-signaling in enteroendocrine K-Cells
Dr. Kyle MooreUniversity of Alabama at BriminghamResident memory-like T cells in an aristolochic acid-induced model of CKD
10/19/22Dr. Tristan ClemonsUniversity of Southern MississippiBio-inspired supramolecular polymers for regenerative medicine applications
12/14/22Dr. Arion KennedyNorth Carolina State UniversityThe role of MHC class I in nonalchologic fatty liver disease